Survival among people hospitalized with COVID-19 in Switzerland: a nationwide population-based analysis

Nanina Anderegg1,2, Radoslaw Panczak3, Matthias Egger3,4,5

  • 1Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland. nanina.anderegg@ispm.unibe.ch.

BMC Medicine
|April 26, 2022
PubMed

Insights

COVID-19 survival rates improved over time. Survival decreased significantly when intensive care unit (ICU) occupancy exceeded 70%, highlighting the need for transmission control measures.

Area of Science:

  • Epidemiology
  • Public Health
  • Critical Care Medicine

Background:

  • Increasing age, male sex, and comorbidities are linked to lower survival rates in SARS-CoV-2 (COVID-19) patients.
  • The complex interactions between these factors and their impact on survival, especially concerning intensive care unit (ICU) occupancy thresholds, remain incompletely understood.

Purpose of the Study:

  • To analyze survival rates of hospitalized COVID-19 patients in Switzerland.
  • To investigate the influence of epidemic wave, patient demographics (age, sex), comorbidities, and ICU occupancy on survival outcomes.

Main Methods:

  • A national, population-based study of 22,648 hospitalized COVID-19 patients in Switzerland (Feb 2020 - Mar 2021).
  • Bayesian survival models were employed to estimate survival, incorporating two-way interactions between age, sex, and comorbidities.
  • ICU occupancy was analyzed using restricted cubic splines to detect non-linear associations with survival.

Main Results:

  • Overall mortality was 21.1% (4785 deaths). Survival improved from the first to the second epidemic wave (76.1% vs. 80.5% at 40 days).
  • Survival remained stable above 81.5% until ICU occupancy reached 70%, after which it declined (78.2% at 80% occupancy).
  • Higher ICU occupancy (>70%) was associated with an estimated 137 excess deaths. Comorbidities impacted younger patients more severely; hypertension and obesity alone did not worsen survival, but hypertension combined with cardiovascular disease did.

Conclusions:

  • COVID-19 survival has improved, likely due to better clinical management.
  • A critical threshold of 70% national ICU occupancy was identified, beyond which survival significantly decreases.
  • Proactive public health interventions to control SARS-CoV-2 transmission are crucial to prevent ICU overload and maintain patient survival rates.
Abstract

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
309
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
472
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
202
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
414
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
141
Censoring Survival Data01:09

Censoring Survival Data

Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
262